Gene Query: TRPV6

Dataset Description Geneva Score
Global modulation of signaling pathways by SARM RAD140 in AR/ER+ breast cancer xenografts 63.14
mRNAseq of Huntington's disease and control patient iPSC-derived brain microvascular endothelial cells 42.4
Integrative analysis identifies targetable CREB1/FoxA1 transcriptional co-regulation as a predictor of prostate cancer recurrence 40.65
Nickel induced transcriptional changes persist post exposure through epigenetic reprograming 32.56
Gene expression alterations of pancreatic intraepithlial neoplasia 31.27
Biased Expression of the FOXP3Δ3 Isoform in Aggressive Bladder Cancer Mediates Differentiation and Cisplatin Chemotherapy Resistance 29.8
Oncogenic Notch promotes long-range regulatory interactions within hyperconnected 3D cliques [HCC1599_RNA-seq] 28.71
Function of HNRNPC in breast cancer cells by controlling the dsRNA-induced interferon response 27.38
TRPS1 shapes YAP/TEAD-dependent transcription in breast cancer cells [RNA-seq] 27.09
TRPS1 shapes YAP/TEAD-dependent transcription in breast cancer cells 27.09
Genistein and bisphenol A exposure cause estrogen receptor 1 to bind thousands of binding sites in a cell type-specific manner 25.93
Gene expression analysis of C4-2 cells treated with ACLY inhibitor and Enzalutamide 23.88
Modeling the MYC-driven normal-to-tumour switch in breast cancer. 23.47
KMT2C medaites the estrogen dependence of breast cancer through regulation of ERα enhancer function 23.36
Long non-coding RNA RP11-19E11.1 is an E2F1 target required for tumor cell proliferation and survival in basal breast cancer 21.37
A combinatorial screen of the CLOUD uncovers a synergy targeting the androgen receptor 18.02
Mapping of DHT-responsive or -independent AR-binding sites induced by activated Src in prostate cancer cell lines 16.95
Mapping of DHT-responsive or -independent AR-binding sites induced by activated Src in prostate cancer cell lines [RNA-seq] 16.95
Molecular pathogenesis of human prostate basal cell hyperplasia reveals a keratinocyte metaplasia 15.64
Transcriptome analysis of virus infected tissues 15.37
RNA-seq profiling identifies Androgen Receptor-regulated genes in prostate cancer cells 15.24
Androgen Receptor-regulated genes in prostate cancer cells 15.24
Regulation of the glucocorticoid receptor via a BET-dependent enhancer drives antiandrogen resistance in prostate cancer 14.94
Human ES Cell-derived Hepatoblasts are an Optimal Lineage Stage for HCV Infection 14.72
The E3 ubiquitin ligase HectD1 suppresses EMT and metastasis by targeting the +TIP protein ACF7 for degradation 14.69
Regulation of cellular heterogeneity and rates of symmetric and asymmetric divisions in triple-negative breast cancer 14.3
mRNA profiling reveals determinants of trastuzumab efficiency in HER2-positive breast cancer 14.13
The Wnt/β-catenin-signaling pathway is modulated by androgen ablation therapy for advanced clinical prostate cancer and contributes to androgen independent cell growth 13.94
Loss of CHD1 facilitates oncogenic hijacking of AR during cancer progression [RNA-seq] 13.85
Loss of CHD1 facilitates oncogenic hijacking of AR during cancer progression 13.85
A common cell state in Triple Negative Breast Cancers represents a druggable vulnerability 13.28
Human islets of varying quality: the good, the (not so) bad and the ugly 12.53
Connexin 32-mediated cell-cell communication is essential for hepatic differentiation from human embryonic stem cells 12.3
Next generation sequencing of advanced non-castrate prostate cancer treated with docetaxel chemotherapy 11.92
RNA-Seq analysis of cSCC cells followed by siRNA-induced gene knockdown of C1s. 10.57
mRNA differential expression in LNCaP cells expressing the wild-type androgen receptor (AR-WT) or the ligand-independent AR-V7 splice variant 10.53
Differential expression in LNCaP cells expressing the wild-type androgen receptor (AR-WT) or the ligand-independent AR-V7 splice variant 10.53
MUC1-C Drives Lineage Plasticity in Progression to Neuroendocrine Prostate Cancer 9.44
SPOP mutation confers intrinsic BET inhibitor resistance in prostate cancer (BRD4_JQ1_RNA-seq) 9.02
Primary human trophoblast from term placenta 8.77
Targeting FOXA1-mediated repression of TGF-β signaling suppresses castration-resistant prostate cancer progression 8.37
Targeting FOXA1-mediated repression of TGF-β signaling suppresses castration-resistant prostate cancer progression [RNA-Seq] 8.37
Overexpression of NFIB and YBX1 in MCF-7 cells 8.19
RNA sequencing Facilitates Quantitative Analysis of luminal breast cancer cells and basal breast cancer cells Transcriptomes 8.06
Hypoxic transcriptome of SQ20B human head and neck cancer cells 7.86
Knockdown of FOXP1 promotes the development of lung adenocarcinoma 7.73
Apatinib preferentially inhibits Gefitinib-resistant lung cancer cells by inducing cell cycle arrest and inhibiting VEGFR signaling pathway 7.49
Epigenetic reprogramming at estrogen-receptor binding sites alters the 3D chromatin landscape in endocrine resistant breast cancer [RNA-seq] 7.47
Epigenetic reprogramming at estrogen-receptor binding sites alters 3D chromatin landscape in endocrine resistant breast cancer 7.47
Gene Expression of Breast Cancer Cell Lines Across Biomaterial Platforms 7.46
Proteostasis by STUB1/HSP70 complex controls sensitivity to androgen receptor targeted therapy in advanced prostate cancer (RNA-Seq) 7.26
Proteostasis by STUB1/HSP70 complex controls sensitivity to androgen receptor targeted therapy in advanced prostate cancer 7.26
Diverse AR-V7 cistromes in castration-resistant prostate cancer are governed by HoxB13 7.13
Arginine citrullination at the C-terminal domain controls RNA Polymerase II transcription 6.91
T47D RNA-seq and ChrRNA-seq data 6.91
Analysis of active enhancers and direct androgen receptor target genes in VCaP prostate cancer cells 6.89
Expression profile of HNF1A knockdown and overexpression in 22RV1 and LNCaP cells respectively 6.89
ChIP-seq of ER and RUNX2 in MCF7 breast cancer cell lines 6.43
Control of prostate tumour growth by the long non-coding RNA GHSROS (LNCaP) 6.28
Gene expression analysis of immortalized human liver progenitor-like cells in culture 6.26
RNA-seq and ChIP-seq analysis of BMI1 or RING1B-silenced prostate cancer cells C4-2 6.17
Transcriptome analysis of human reninomas as an approach to understanding juxtaglomerular cell biology 5.84
Defective transcription elongation in a subset of cancers confers immunotherapy resistance (human cell lines RNA-Seq) 5.73
RNA-sequencing analysis of human fibrolamellar hepatocellular carcinoma and 4 maturational stages of the human hepatobiliary system 5.58
Stem cell and neurogenic gene-expression profiles link prostate basal cells to aggressive prostate cancer 5.43
Gene expression profiling of patient's DCIS-IDC tandem lesions by RNA sequencing analysis 5.35
Characterization of sperm lncRNA and its differently expression in the sperm of asthenozoospermic patients 5.25
Identification of Differentially Expressed Splice Variants by the Proteogenomic Pipeline Splicify 5.09
RNAseq analysis of ESRP regulated splicing events in prostate cancer 5.05
A Basal Stem Cell Signature Identifies Aggressive Prostate Cancer Phenotypes 4.92
RNA sequencing of prostate cancer and normal tissue from African Americans and European Americans 4.89
Comprehensive comparative analysis of RNA sequencing methods for degraded or low input samples 4.85
BRG1 governs Glucocorticoid Receptor interactions with chromatin and pioneer factors across the genome 4.81
Nuclear receptor RORγ is a targetable master regulator of cholesterol in a subtype of breast cancer 4.76
LIN28A modulates splicing and gene expression programs in breast cancer cells [RNA-Seq] 4.68
LIN28A modulates splicing and gene expression programs in breast cancer cells 4.68
Nuclear receptor RORγ is a targetable master regulator of cholesterol in a subtype of breast cancer [RNA-Seq] 4.63
Integrin signaling regulates YAP/TAZ to control skin homeostasis 4.58
circNFIB suppresses lymphatic metastasis of pancreatic cancer 4.57
Bulk RNA-sequencing of cell types isolated by FACS from normal human prostates 4.55
Genome-wide RNA-sequencing of human islets 48 hour after transduction with adenoviruses expressing either GFP (control), or histone chaperone ASF1B. 4.52
Gene expression by high-throughput sequencing of T47D-MTVL human breast cancer cells upon H1.4 knock-down and multiple H1 variants 4.5
Characterization of macrophage - cancer cell crosstalk in estrogen receptor positive and triple-negative breast cancer 4.5
Dynamics of Proteo-Transcriptomic Response to HIV-1 Infection 4.49
Assembly of methylated LSD1 and CHD1 drives AR-dependent transcription and translocation 4.49
Assembly of methylated LSD1 and CHD1 drives AR-dependent transcription and translocation [RNA-Seq] 4.49
RNAseq of Breast cancer PDX samples 4.39
Illumina Human Polycystic Liver Disease and Normal Biliary Stem Cell RNAseq 4.34
AKT Inhibition Promotes Non-autonomous Cancer Cell Survival [RNA-Seq] 4.23
AKT Inhibition Promotes Non-autonomous Cancer Cell Survival 4.23
Transcriptome profiling of CXCR2+ neuroendocrine (NE) tumor cells purified from patients' fresh prostate adenocarcinoma 4.18
Expression profile of LNCaP/AR cells with or without HNF4G expression grown for long term in charcoal stripped-serum (CSS) media 4.12
Polycomb complexes associate with enhancers to promote oncogenic transcriptional programs in cancer 4.09
Effect of SF3B1 suppression in cancer cells with different SF3B1 copy-number levels 4.03
Supraphysiological Androgens Repress Prostate Cancer Growth and Induce DNA Damage Augmented by PARP Inhibition 3.88
Global loss of epigenetic and transcriptional fidility defines a subclass of cancer with immunotherapy resistance 3.8
Transcriptome analysis of immature and matured human oocytes from patients of young and advanced maternal age 3.75
Paxillin regulates genomic networks in prostate cancer [LNCaP] 3.74
HNRNPL and its RNA Targets in Prostate Cancer 3.56
Regulartory effect of HNRNPL and LARP on RNA expression in LNCaP prostate cancer cells 3.56
HEK293 Heat-shock experiment 3.56
Somatic cell fusions reveal extensive heterogeneity in basal-like breast cancer 3.54
Somatic cell fusions reveal extensive heterogeneity in basal-like breast cancer [RNA-Seq] 3.54
APOBEC mutation drives early-onset squamous cell carcinomas in recessive dystrophic epidermolysis bullosa 3.53
siRNA-mediated silencing of ORAI3 in MDA-MB-468 breast cancer cells exposed to hypoxia 3.46
Transcriptome sequencing of differentially expressed genes in mouse and human skin with and without NCSTN mutation 3.45
Transcriptome sequencing of differentially expressed genes in acne inversa (AI) patients with NCSTN mutation and healthy individuals 3.45
RNA-seq analysis of breast cancer 3.44
RNA-seq analysis and shRNA screen of breast cancer 3.44
Epigenomic plasticity enables human pancreatic alpha to beta cell reprogramming 3.3
Transcriptome sequencing after MAGOHB knockdown in MAGOH-deleted or non-deleted cancer cells 3.27
Paxillin regulates genomic networks in prostate cancer [C4-2] 3.24
Selective Inhibition of the Second Bromodomain of BET Family Maintains Anti-Tumor Efficacy and Improves Tolerability (LNCaP RNA-seq) 3.22
Transcriptome analysis of VCaP xenografts resistant to dual therapy with abiraterone and enzalutamide 3.18
Polycomb- and Methylation-Independent Roles of EZH2 as a Transcription Activator 3.15
Polycomb- and Methylation-Independent Roles of EZH2 as a Transcription Activator [RNA-seq] 3.15
Conserved roles for murine mDUX and human DUX4 in activating cleavage stage genes and MERVL/HERVL retrotransposons [RNA-Seq] 3.14
RNA sequencing based comparative analysis of human hepatic progenitor cells and their niche from alcoholic steatohepatitis livers 3.14
RNA m5C Methylation in breast cancer using MeRIP-Seq 3.09
Evaluation of RNA amplification and RNA-Seq library preparation protocols for spermatozoa RNA profiling 2.93
Next Generation Sequencing Facilitates Quantitative Analysis of UVB(20mJ/cm2 and 40mJ/cm2) exposed and untreated HaCaT keratinocytes Transcriptomes 2.91
Reducing the structure bias of RNA-Seq reveals a large number of non-annotated non-coding RNA 2.9
Expression profiling and occupancy after knockdown or over-expression of HFN1A or HNF4G in prostate cancer cells 2.84
Long Non-coding RNA PICSAR Promotes Growth of Cutaneous Squamous Cell Carcinoma by Regulating ERK1/2 Activity 2.83
Fusion discovery in breast cancer cell line 2.82
Transcriptomic profiling of sequential tumours from breast cancer patients provides a global view of metastatic expression changes following endocrine therapy 2.82
Codon usage optimization in pluripotent embryonic stem cells [RNA-seq] 2.77
ROR-γ drives androgen-receptor expression and represents a therapeutic target in castration-resistant prostate cancer 2.76
Gene expression patterns define the hepatocyte-like cells derived by different strategies [RNA-seq] 2.74
Gene expression patterns define the hepatocyte-like cells derived by different strategies 2.74
FOXD3 is a novel tumor suppressor in lung cancer 2.71
ONECUT2 Drives Neuroendocrine Prostate Cancer Through Hypoxia Signaling 2.65
Evolved Labels of Placental Invasion in Human and Bovine Endometrial Stroma 2.58
Xeno-free and Chemically Defined Human System for Culturing Human Epidermal Keratinocytes 2.54
Short and long-term effects of CDK4/6 inhibition on early stage breast cancer 2.5
Gene expression profile difference among renal location in a stone former 2.47
Lipid degradation promotes prostate cancer cell survival 2.43
Targeting the androgen receptor N-terminus via the cochaperone Bag-1L [RNA-Seq KO] 2.42
Genome-wide functional assessment of enhancer activities in the human genome 2.39
Transcriptome profiling of Normal and Cancerous Prostate Cells 2.38
A prostate cancer chromatin interaction map 2.37
Gene expression profile in breast cancer cell lines using RNA sequencing 2.36
Discovery of cis-spliced chimeric RNAs between adjacent genes in human prostate cells 2.34
Differences in miRNA Detection Levels are Technology and Sequence Dependent 2.26
Differences in miRNA Detection Levels are Technology and Sequence Dependent [NGS] 2.26
AR-independent prostate cancer is sustained through FGF signaling 2.24
Subclonal cooperation drives metastasis through modulating local and systemic immune microenvironments 2.23
Quantitative profiling of the UGT transcriptome in human drug metabolizing tissues [Total RNA] 2.18
Gene expression analysis of human liver progenitor-like cells in culture 2.13
Illumina HiSeq Sequencing on Breast cancer PDX samples 2.11
SILAC identifies LAD1 as an oncogenic filamin binder regulating actin dynamics in response to EGF and marking aggressive breast tumors 2.1
Epigenetic modulation of β-cells by interferon-α via PNPT11-miR-26a-TET2 triggers autoimmune diabetes [RNA-seq] 2.09
Epigenetic modulation of β-cells by interferon-α via PNPT11-miR-26a-TET2 triggers autoimmune diabetes 2.09
Defective transcription elongation in a subset of cancers confers immunotherapy resistance 2.09
Replicated transcriptome profiling of Normal and Cancerous Prostate Cells [RNA-Seq] 2.07
Three-dimensional disorganisation of the cancer genome occurs coincident with long range genetic and epigenetic alterations [RNA-seq] 2.06
Three-dimensional disorganisation of the cancer genome occurs coincident with long range genetic and epigenetic alterations 2.06
ML29755 RNA-seq data 2.03
TALEN-based knockout of mir-141 and mir-200c in SK-BR-3 cells 2.02
Expression by CD133+ cells isolated from the adult human exocrine pancreas 2.02
RNA-seq of cancer cell lines treated with T-025 2.01
RNA sequencing of prostate cancers reveal insights on the prognostic significance of visibility on multi-parametric MRI 1.95
Repression of stress-induced LINE-1 expression protects cancer cell populations from lethal drug-exposures [RNA-Seq] 1.94
Repression of stress-induced LINE-1 expression protects cancer cell populations from lethal drug-exposures 1.94
Epigenome regulation during epidermal lineage commitment [RNA-seq] 1.94
Evidence for HOXC6 as a potential molecular marker for non-small cell lung cancer 1.93
H3B-8800, a novel oral splicing modulator, induces lethality in spliceosome mutant cancers [K562] 1.93
Characterizing the contrasting roles of JMJD3 and UTX histone demethylases in T cell acute lymphoblastic leukemia [short_hairpins_RNA-seq] 1.92
Human Hepatocytes with Drug Metabolic Function Induced from Fibroblasts by Lineage Reprogramming 1.92
Super-enhancer-driven CCAT1 is co-activated by SOX2 and TP63 and promotes squamous cancer from esophagus, head and neck and lung [RNA-seq] 1.88
Super-enhancer-driven CCAT1 is co-activated by SOX2 and TP63 and promotes squamous cancer from esophagus, head and neck and lung 1.88
Transcripotome analysis of different locations of hair follicles (bulb, bulge) in androgenetic alopecia 1.87
Resistance to BET inhibitor leads to new therapeutic vulnerabilities in castration resistant prostate cancer 1.85
Identification of HOXB13 target genes responsive to BET inhibitors 1.83
eRNA: A graphic user interface-based tool for RNA sequencing data analysis [mRNA-Seq] 1.82
eRNA: A graphic user interface-based tool for RNA sequencing data analysis 1.82
CDK4/6 inhibitor resistance in prostate cancer 1.81
SPOP mutation confers intrinsic BET inhibitor resistance in prostate cancer 1.76
5hmC and gene expression data in breast cancer cell lines treated with an antioxidant 1.75
Dynamic gene expression in T-ALL following treatment and release of gamma-secretase inhibition [GRO-Seq] 1.71
Differentially expressed genes during pancreatic bud differentiation in cellular aggregates 1.7
Next Generation Sequencing of isolated EGFR+ and HLA-G+ first trimester human trophoblasts 1.7
SIX4 acts as a master regulator of genes associated with the malignant phenotype of non-small cell lung cancer cells 1.64
A MYC/GCN2/eIF2alpha negative feedback loop limits protein synthesis to prevent MYC-dependent apoptosis in colorectal cancer 1.64
Human germ cell formation in xenotransplants of induced pluripotent stem cells carrying X chromosome aneuploidies 1.62
Transcription-dependent control of stem cell self-renewal and differentiation by the splicing factor U2AF1 1.6
Analysis of transcriptional differences after IFN-beta (IFN-b) or IFN-lambda (IFN-l) treated human mid-gestation chorionic villus explants 1.59
Transcriptional analysis of ZIKV-infected Ifnar-/- and Ifnar+/- placentas and IFN-beta (IFN-b) or IFN-lambda (IFN-l) treated human mid-gestation chorionic villus explants 1.59
Effect of PBK knockdown on C4-2 cell transcriptome 1.57
The inhibitory effect of TIAM1 on TAZ transcriptional activity and TIAM1 differentially expressed genes 1.49
List of TIAM1 differentially expressed genes in SW620 cells [RNA-seq] 1.49
Whole Transcriptomic Sequencing of Metastatic Castration Resistant Prostate Cancer Samples 1.47
Modeling genome-wide transcriptional cis-regulation in n LNCaP-abl cell line after siRNA knock down of a series of gene factors [RNA-seq] 1.46
Pancreatic Beta Cell Enhancers Regulate Rhythmic Transcription of Exocyst Triggering and Diabetes 1.45
Genome-wide Circadian Control of Transcription at Active Enhancers Regulates Insulin Secretion and Diabetes Risk 1.45
GREB1 amplifies androgen receptor output in prostate cancer and contributes to antiandrogen resistance 1.43
Oncogenic Notch promotes long-range regulatory interactions within hyperconnected 3D cliques 1.43
Gene expression profiles of rescue with wild type or SUMO double mutant TRIM24 1.41
Genome wide impact of loss of mechanoluminal stimulation on neonatal intestine 1.36
Transcriptomic analysis of acute mitochondrial pyruvate carrier inhibition using UK5099 in ABL prostate cancer cells 1.35
Effect of Hypoxia in Severe Preeclampsia through Epigenetic Regulation 1.35
Generating Patterned Kidney Organoids for Studying Development and Diseases [bulk RNA-Seq] 1.33
Role for citron kinase in prostate cancer growth 1.31
MicroRNA-mediated suppression of the TGF-β pathway confers transmissible and reversible CDK4/6 inhibitor resistance 1.3
MicroRNA-mediated suppression of the TGF-β pathway confers transmissible and reversible CDK4/6 inhibitor resistance (RNA-Seq) 1.3
Transcriptomics analysis of enteroendocrine cells following vertical sleeve gastrectomy 1.27
Transcriptomics analysis of human jejunal enteroendocrine cells after vertical sleeve gastrectomy 1.27
Intrinsic histone acetyltransferase activity of BRD4 is responsible for nucleosome eviction and transcriptional activation 1.26
Effect of PDZ domain binding Kinase inhibition using TOPK-32 (called PBKi) on C4-2 cell transcriptome 1.24
RNA-sequencing of tamoxifen-resistant and -sensitive breast cancer cell lines. 1.24
RNA-Seq analysis of cSCC cells followed by siRNA-induced gene knockdown of AIM2. 1.24
Generation of mature lung alveolar epithelial cells from human pluripotent stem cells 1.24
Integrated analysis of MLL-AF9 AML patients and model leukemias highlights RET and other novel therapeutic targets (RNA-seq AML development) 1.24
A practical evaluation of alignment algorithms for RNA variant calling analysis 1.23
Grainyhead-like 2 is essential for androgen receptor expression and activity in prostate cancer (RNA-seq) 1.23
Grainyhead-like 2 is essential for androgen receptor expression and activity in prostate cancer 1.23
Research resource: global identification of estrogen receptor β target genes in triple negative breast cancer cells 1.21
Genes regulated by soluble guanylyl cyclase in VCaP prostate cancer cells 1.21
HNRNPM-regulated splicing dependencies in prostate cancer 1.2
HNRNPM-regulated splicing dependencies in prostate cancer [RNA-Seq] 1.2
Comparison of expression profiles of APP-depleted prostate cancer cells (LNCaP) 1.19
Effect of CHKA knockdown on C4-2 cell transcriptome 1.17
Divergent expression and metabolic functions of human glucuronosyltransferases through alternative splicing 1.14
Epigenome regulation during epidermal lineage commitment 1.13
Differential gene expression tools exhibit substandard performance for long non-coding RNA-sequencing data 1.11
SHQ1 regulation of RNA splicing is required for T-lymphoblastic leukemia cell survival 1.11
Transcriptome sequencing reveals aberrant alternative splicing in Huntington's disease 1.09
Identification of microRNA-dependent gene regulatory networks driving human pancreatic endocrine cell differentiation [RNA-Seq III] 1.09
CREB5 promotes resistance to androgen-receptor antagonists and androgen deprivation in prostate cancer 1.08
Profiling in vivo Bone Lesion (IVBL) and Orthotopic tumors by Next Generation Sequencing 1.07
Mesothelioma xenografts in nude mice: PBS treated versus pirfenidone treated 1.07
Locally transplanted human urine-induced nephron progenitor cells contribute to renal repair in mice kidney with diabetic nephropathy 1.05
Identification of Tissue-Specific Protein-Coding and Noncoding Transcripts across 14 Human Tissues Using RNA-seq 1.05
Reconstituting development of pancreatic intraepithelial neoplasia from primary human pancreas duct cells 1.04
The Notch driven long non-coding RNA repertoire in T-cell acute lymphoblastic leukemia 1.03
Reassessment of Exosome Composition 1.02
Identification of an NKX3.1-G9a-UTY regulatory network that controls prostate differentiation (Human_RWPE1_RNA-Seq) 1.01
Identification of an NKX3.1-G9a-UTY regulatory network that controls prostate differentiation 1.01
Discovery of naturally occurring ESR1 mutations during acquisition of resistance to endocrine therapy in widely used estrogen receptor positive breast cancer cell lines 1.01
Discovery of naturally occurring ESR1 mutations during acquisition of resistance to endocrine therapy in widely used estrogen receptor positive breast cancer cell lines [RNA-Seq] 1.01
RNA-Seq analysis of prostate cancer cell line LNCaP treated with vehicle, androgen, androgen and IMTPPE, androgen and JJ-(+)-450, androgen and JJ-(-)450, androgen and enzalutamide 1.01
RNAseq analysis of ruxolitinib treated breast cancers 1.0
NOTCH signaling is activated in and contributes to resistance in enzalutamide-resistant prostate cancer cells 0.99
Targeted enhancer activation by a subunit of the integrator complex 0.99
Expression data for HT29 cells treated with 5-aza-deoxy-cytidine 0.96
Expression data for HT29 cells treated with 5-aza-deoxy-cytidine [RNA-Seq] 0.96
RNA sequencing of lesional and nonlesional skin from patients with atopic dermatitis 0.94
Nuclear HNRNPA2B1 HITS-CLIP and RNA-seq 0.92
Dexamethasone inhibits respiratory syncytial virus-driven mucus production while increasing viral replication without altering antiviral interferon signaling 0.91
Transcriptomics profiles of patient-matched normal kidney and ccRCC pairs 0.91
Transciptomic profiling of human fetal lung samples 0.89
Interactions of aCPs with Cytosine-rich Polypyrimidine Tracts Enhance Splicing of Cassette Exons 0.86
RNA sequencing for PDX1, NGN3 and MAFA transduced iPSCs cell 0.86
Inhibition of ERG Activity in Patient Derived Prostate Cancer Xenografts using the Small Molecule Inhibitor YK-4-279 0.86
Genome-wide RNA-sequencing (RNA-seq) of benign and malignant prostate cell lines without and with androgen (R1881) stimulation. 0.86
Identification of expressed and conserved human non-coding RNAs 0.83
Comparative total RNA and mRNA sequencing and systems analysis reveals nascent transcriptional response to early HIV-1 infection in a CD4+ T cell line 0.82
Combined inhibition of STAT3 and DNA repair in palbociclib-resistant ER-positive breast cancer 0.82
Transcriptomic analysis of frontal fibrosing alopecia 0.79
The gene expression profiles of gallbladder cancer 0.77
Osmostress induced changes of chromatin architecture and transcription in mammalian cells 0.76
Osmostress induced changes of chromatin architecture and transcription in mammalian cells [RNA-Seq, HiC] 0.76
Genome-wide Analysis of Chromatin Interactions in Human Cells 0.76
G-quadruplex structures mark human regulatory chromatin 0.76
Identification of global XBP1s target gene expression in human prostate cancer cells 0.75
Dtx3L and Androgen Signaling in Prostate Cancer 0.72
Massive parallel sequencing uncovers actionable FGFR2-PPHLN1 fusion and ARAF mutations in intrahepatic cholangiocarcinoma 0.71
Genome-wide identification of cancer-specific alternative splicing in circRNA 0.71
Gene expression and genome-wide location analysis of breast cancer cell-lines 0.68
Gene expression analysis of breast cancer cell-lines 0.68
mRNA-sequencing of breast cancer subtypes and normal tissue 0.68
Next Generation Sequencing Facilitates Quantitative Analysis of ALDH+ E-BCSC, CD24-CD44+ M-BCSC and Bulk tumor cell Transcriptomes from MC1 and Vari068 PDX models of TNBC 0.66
A robust qualitative transcriptional signature for the early diagnosis of gastric cancer 0.65
Targeting the androgen receptor N-terminus via the cochaperone Bag-1L 0.64
The flightless I protein is involved in the genome-wide mRNA post-transcriptional regulation in lung carcinoma cells 0.63
Transcriptome analysis of PC9 cells with gefitinib or/and hypoxia treatment and comparison with gefitinib resistant PC9 cells and ALDH positive PC9 cells 0.6
Transcriptomic responses to Ivacaftor and prediction of Ivacaftor clinical responsiveness 0.6
Silencing p300 in MCF7 cells to study expression and alternative splicing 0.6
Metastasis in triple negative breast cancer is dependent on ΔNp63/CXCL2/CCL22-mediated recruitment of myeloid-derived suppressor cells 0.59
Measure transcript integrity using RNA-seq data 0.59
Endometrial transcriptome and PGR cistrome in cycling fertile women [RNA-seq] 0.58
Endometrial transcriptome and PGR cistrome in cycling fertile women 0.58
Cistromic re-programming by truncating GATA3 mutations promotes mesenchymal transformation in vitro, but not mammary tumour formation in mice [RNA-seq] 0.58
Cistromic re-programming by truncating GATA3 mutations promotes mesenchymal transformation in vitro, but not mammary tumour formation in mice 0.58
PR isoform-specific ER and PR chromatin binding and gene expression observed in-vitro in breast cancer cells. 0.57
Identification of the RB loss-induced transcriptome in prostate cancer [RNA] 0.57
Identification of the RB loss-induced transcriptome and E2F1 cistrome in prostate cancer 0.57
RNA-seq data of small cell carcinoma of the bladder (SCCB) /urothelial carcinoma (Non-SCCB) clinical samples, and bladder-PARCB cell lines 0.57
Apoptotic endothelial cells release small extracellular vesicles loaded with immunostimulatory viral-like RNAs 0.56
Transcriptome of EBV-infected gastric cancer cell lines 0.56
The Human Testis Cell Atlas via Single-cell RNA-seq 0.56
LNCaP treated with iBET 0.56
RNA-seq analysis of BORIS/CTCFL knockdown in K562 cell line 0.55
RNA-seq and small RNA-seq analysis of BORIS/CTCFL knockdown in K562 cell line 0.55
The dynamics of cellular response to therapeutic perturbation using multiplexed quantification of the proteome and transcriptome at single-cell resolution 0.55
LncRNA-dependent mechanisms of androgen receptor-regulated gene activation programs 0.55
Gene expression for surgically treated pancreatic cancer after one neoadjuvant vaccine dose 0.55
Global epigenomic reconfiguration during mammalian brain development 0.55
RNA-seq analysis of the human fetal kidney. 0.55
Next-generation RNA sequencing to determine changes in gene expression during breast cancer progression 0.55
Transcriptome analysis of human lung epithelial cells 0.54
Identification of miRNA signatures during the differentiation of hESCs into retinal pigment epithelial cells 0.54
Effect of selective glucocorticoid receptor modulation (SGRM) on gene expression in human prostate cancer cell lines 0.53
High-throughput RNA sequencing on circular RNA profiles of human bladder cancer tissues and normal bladder tissues 0.52
RNA-seq of exosomes identifies lncRNA profiles that distinguish early-stage esophageal squamous cell carcinoma (ESCC) from non-malignant esophagitis 0.51
Sequencing-based analyses characterize a tumor suppressive role of mir-1271 repressed by DNA hypermethylation in gastric cancer 0.51
RNA-Seq of Kaposi’s sarcoma reveal alterations in glucose and lipid metabolism 0.5
Risk SNPs mediated promoter-enhancer switching promotes prostate cancer progression through lncRNA PCAT19 0.5
Risk SNPs mediated promoter-enhancer switching promotes prostate cancer progression through lncRNA PCAT19 (RNA-seq data sets) 0.5
Clinical and genomic crosstalk between glucocorticoid receptor and estrogen receptor α in endometrial cancer [RNA-seq] 0.5
Clinical and genomic crosstalk between glucocorticoid receptor and estrogen receptor α in endometrial cancer 0.5
A role for p53 in the adaptation to glutamine starvation through the expression of Slc1a3 0.5
LncPRESS1 is a p53-regulated lncRNA that safeguards pluripotency by disrupting SIRT6 mediated de-acetylation of histone H3K56 0.49
ARID1A and ARID1B loss in HCT116 cells 0.49
RNA-seq in HT-29 colorectal cancer cells after F. nucleatum treatment 0.49
The Molecular Dissection of the Oncogenic Role of ETS1 in the Mesenchymal Subtypes of Head and Neck Squamous Cell Carcinoma [RNA-seq Cell lines] 0.48
Neuronal brain region-specific DNA methylation and chromatin accessibility are associated with neuropsychiatric trait heritability [RNA-Seq] 0.48
Neuronal brain region-specific DNA methylation and chromatin accessibility are associated with neuropsychiatric trait heritability 0.48
The regulation of ferroptosis by TAZ in epithelial ovarian cancer 0.48
Runx1 stabilizes the mammary epithelial cell phenotype and prevents epithelial to mesenchymal transition 0.47
Integrating the Epigenome to Identify Novel Drivers of Hepatocellular Carcinoma 0.45
iPSC-Derived Cholangiocytes 0.45
Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and SMAD4 Y95 Mutation Transcriptomes 0.45
Reconstitution of the human pancreatic niche stimulates differentiation of hESCs into beta cells and reveals new signals for pancreatic endocrine cell maturation 0.44
Human optic chiasm from healthy controls and multiple sclerosis patients 0.44
Multiple sclerosis and EAE 0.44
RNA-seq analysis of melanoma and carcinoma cells expressing FOXQ1 0.44
RNA sequencing of Formalin-Fixed, Paraffin-Embedded Specimens for Gene Expression Quantification and Data Mining 0.44
RNA sequencing for human induced pluripotent stem cell cardiomyocyte differentiation 0.43
Targets of CDK12 on ZR-75-30 breast cancer cells (RNA-seq) 0.42
RNAseq of CCRF-CEM, a T-cell acute lymphoblastic leukemia cell line, after knockdown with 2 control hairpins and 6 hairpins targeting the PRC2 complex. 0.42
The long non-coding RNA MALAT1 contributes to the pathogenesis of multiple sclerosis through alternative splicing and backsplicing regulation 0.41
Potent and targeted activation of HIV-1 using the CRISPR/Cas9 activator Complex 0.4
Characterization of Type I Interferon pathway during Hepatic Differentiation of Human Pluripotent Stem Cells and hepatitis C virus infection 0.4
Transcriptomic profile of T cell acute lymphoblastic leukemia (T-ALL) cell from patients in CHCQMU 0.39
RNAseq of T-ALL upon long non coding rna purturbation 0.39
Molecular analysis of high-grade serous ovarian carcinoma with and without associated serous tubal intra-epithelial carcinoma [RNA-Seq; normal samples] 0.39
Prostate Cancer Cell RNA-Seq (PC3E and GS689.Li) 0.39
Transcriptomic Reprogramming of Prostate Cancer Cells Driven by Stroma-Derived SPINK1 0.39
RNA profiling Analysis of the Serum Exosomes Derived from Active and Latent M.tuberculosis infectious Patients 0.39
Effects of Polybrominated Diphenyl Ether (PBDE) Mixture on estrogen receptor positive (ER+) patient-derived tumor xenograft (PDX) model 0.39
mRNA expression data from ESCs derived by polar body transfer reconstructed embryos (PBTESCs) 0.39
RNA-seq analysis of SLIRP knockdown with 1nM DHT in LNCaP cells 0.38
Critical role of transient activation of human endogenous retroviruses during reprogramming toward pluripotency (RNA-Seq) 0.36
Critical role of transient activation of human endogenous retroviruses during reprogramming toward pluripotency 0.36
Increased Serine and One Carbon Pathway Metabolism by PKCl/i Deficiency Promotes Neuroendocrine Prostate Cancer [RNA-seq] 0.36
Increased Serine and One Carbon Pathway Metabolism by PKCl/i Deficiency Promotes Neuroendocrine Prostate Cancer 0.36
Directed differentiation of human embryonic stem cells to corneal endothelial cell-like cells: A transcriptomic analysis 0.35
Comprehensive Transcriptome Analysis of Cerebral Cavernous Malformation Across Multiple Species and Genotypes 0.35
Short-term effect of Boost versus Radical doses of Intraoperative electron Radiotherapy in breast cancer tumor bed using high-throughput approaches 0.35
Comparing oestrogen-responsive genes in endometrial and breast cancer cell lines 0.35
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [Toxin] 0.34
Generating Patterned Kidney Organoids for Studying Development and Diseases 0.34
Targeting the androgen receptor N-terminus via the cochaperone Bag-1L [RNA-seq C-terminal mutant] 0.34
RNA-Seq with DHT induction and/or GSK treatment at 24, 48 hrs and 2 weeks 0.34
FOXA1 Chromatin Binding is Regulated by LSD1-Mediated Demethylation 0.34
Evaluation of the immunogenicity of live-attenuated influenza vaccines in nasal epithelial cells in primary differentiated human nasal epithelial cells [RNA-Seq] 0.34
Evaluation of the immunogenicity of live-attenuated influenza vaccines in nasal epithelial cells in primary differentiated human nasal epithelial cells 0.34
Sequence dependency and regulatory function of dimeric NOTCH1/RBPJ complexes on coding and non-coding transcription in T-lymphoblastic leukemia 0.34
circRNA-sequencing 0.33
RNA seq analysis of human Fetal and adult derived Enterospheres 0.33
Single cell analysis of smooth muscle cell phenotypic modulation in vivo during disease in mice and humans 0.33
Single cell analysis of smooth muscle cell phenotypic modulation in vivo during disease in mice and humans [human scRNA-seq] 0.33
RNA-Seq analysis of Head and Neck Squamous cell carcinoma cell-lines 0.33
RNA sequencing of human pancreatic cancer cell lines 0.33
Investigate A2M treatment on human prostate cancer and mouse liver 0.32
Investigate A2M treatment on human prostate cancer xenograft in mice 0.32
Antiviral innate immunity of hepatitis C virus-infected stem cell-derived hepatocytes 0.32
RNA-seq analysis of Retinoic Acid and Non-treated Control hiPSCs 0.31
Selective expansion of myeloid and NK cells in humanized mice yields human-like vaccine responses (Experiment 2: scRNA-seq) 0.31
Estrogen-independent molecular actions of mutant estrogen receptor alpha in endometrial cancer 0.3
Estrogen-independent molecular actions of mutant estrogen receptor alpha in endometrial cancer [RNA-seq] 0.3
A single-cell transcriptome atlas of the human pancreas 0.3
Circular RNAs are down-regulated in KRAS mutant colon cancer cells and can be transferred to exosomes 0.3
The expression profiles of GBC liver metastasis 0.3
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [UNSWCD] 0.29
Transcriptional profiling of JEG3 cells with HLA-G ablation via deletion of Enhancer L 0.29
Tracing Enhancer Networks using Epigenetic Traits (TENET) 0.29
ChIPseq and RNAseq analysis of T47D cells with/without silencing TRPS1/CHD4 0.28
RNA-Seq identifies condition-specific biological signatures of ischemia-reperfusion injury in the human kidney 0.28
Abnormal RNA splicing and genomic instability after induction of DNMT3A mutations by CRISPR/Cas9 gene editing 0.27
Abnormal RNA splicing and genomic instability after induction of DNMT3A mutations by CRISPR/Cas9 gene editing [RNA-Seq] 0.27
RNA isoform screens reveal the essentiality and tumor suppressor activity of ultraconserved poison exons 0.26
Global gene expression profiles of cardiac progenitors differentiated from human pluripotent stem cells in 3D culture under simulated microgravity 0.26
Circular RNAs are super abundant in cervical tumor and plasma detected by high throughput microarray [RNA-Seq] 0.26
Circular RNAs are super abundant in cervical tumor and plasma detected by high throughput microarray 0.26
mRNA sequencing of highly and lowly metastatic human colorectal cancer PDXs 0.26
The conserved transcriptional landscapes in human spermatogenesis 0.25
Transcriptome profiling of a mouse model of alveolar soft part sarcoma 0.25
Transcriptional differences between skin from patients with atopic dermatitis and control skin obtained from the healthy margins of Mohs surgery patients 0.25
The anti-leukemic effect of R-2HG depends on its acting as an m6A mRNA modifier-RNA Seq-PBS / R-2HG treatment 0.24
TT-seq captures simultaneous activation of eRNAs and promoters during T cell activation 0.24
Single-cell survey of human lymphatics unveils marked endothelial cell heterogeneity and mechanisms of homing for neutrophils 0.23
lncRNA-PCAT1 knockdown effect on the gene expression of androgen independent LNCaP (LNCaP-AI) cell line 0.23
LncRNA-dependent mechanisms of androgen receptor-regulated gene activation programs [GRO-seq II] 0.23
CDK12 regulates alternative last exon mRNA splicing and promotes invasion of a breast cancer cell line 0.23
Next generation sequencing of small RNAs isolated from exosomes in human semen 0.22
Integrative Genomic and Transcriptomic Analysis Identified Candidate Genes Implicated in the Pathogenesis of Hepatosplenic T-cell Lymphoma 0.22
Hepatosplenic T cell lymphoma 0.22
Transcriptomics profiling of Alzheimer’s disease reveal novel molecular targets 0.22
Priming mobilization of hair follicle stem cells triggers permanent loss of regeneration after alkylating chemotherapy 0.21
SREBP1 drives Keratin 80-dependent cytoskeletal changes and invasive behavior in endocrine resistant ERα breast cancer 0.2
Unlocking the transcriptomic potential of formalin-fixed paraffin embedded clinical tissues: Comparison of gene expression profiling approaches [RNA-Seq] 0.2
Unlocking the transcriptomic potential of formalin-fixed paraffin embedded clinical tissues: Comparison of gene expression profiling approaches 0.2
Genome-wide expression from the esophageal biopsies of subjects with and without eosinophilic esophagitis 0.2
Conversion of Human Gastric Epithelial Cells to Multipotent Endodermal Progenitors using Defined Small Molecules [gene expression] 0.19
Conversion of Human Gastric Epithelial Cells to Multipotent Endodermal Progenitors using Defined Small Molecules 0.19
U2AF1 mutations alter splice site recognition in hematological malignancies 0.19
Single Cell RNA-sequencing of cell types isolated by FACS from normal human prostates 0.19
A genomic study of the contribution of DNA methylation to regulatory evolution in primates 0.19
Age-Related Gene Expression Changes in Prostate Cancer Patients [RNA-Seq] 0.18
Age-Related Gene Expression Changes in Prostate Cancer Patients 0.18
Human gut derived-organoids as model to study gluten response and effects of microbiota bioproducts in celiac disease 0.18
Single-cell Transcriptomics reveals multi-step adaptations to endocrine therapy 0.18
RNA-Seq and ChIP-Seq reveals SQSTM1/p62 as a key mediator of JunB suppression of NF-kB-dependent inflammation 0.17
JunB control of keratinocyte-mediated inflammation [RNA-seq] 0.17
STX4 Over-Expression in Human islets 0.17
Human colon organoids reveal distinct physiologic and oncogenic Wnt responses 0.17
Contribution of SRF and Nkx2-5 to androgen-dependent gene expression in prostate cancer 0.17
Gene expression profiling in follicular lymphoma (FL) samples and paired transformed follicular lymphoma (tFL) (n=6 samples) 0.16
The serine hydroxymethyltransferase-2 (SHMT2) initiates lymphoma development through epigenetic tumor suppressor silencing. 0.16
Probing the Global Cellular Responses to Lipotoxicity Caused by Saturated Fatty Acids 0.16
DLX3 alters transcriptomic profile of adhesion, cell cycle, and cell death in Squamous Cell Carcinoma Cells 0.16
DLX3-dependent p53 signaling network controls keratinocyte cell cycle and squamous tumor growth 0.16
Bioreactor-engineered cancer tissues mimic phenotypes, gene expression profiles and drug resistance mechanisms detectable in xenografts and clinical specimens. 0.16
Evaluation of the effectiveness of semen collection and sperm purification methods for spermatozoa transcript profiling 0.16
Patient Derived Xenograft for Delivery of Precision Medicine in Castrate Resistant Prostate Cancer 0.16
Targeting miR-155 restores abnormal microglia and attenuates disease in SOD1 mice 0.15
miR-155 plays a crucial role in ALS and is an immune therapeutic target [RNA-Seq] 0.15
The mRNA expression analysis of psoriasis skin lesion mesenchymal stem cell 0.15
Novel kinase fusion oncogenes in post-Chernobyl radiation-induced pediatric thyroid cancers 0.15
O-GlcNAc transferase fine-tunes MYC-dependent transcription to promote cell cycle 0.14
O-GlcNAc transferase fine-tunes MYC-dependent transcription to promote cell cycle [RNA-seq] 0.14
Identification of microRNA-dependent gene regulatory networks driving human pancreatic endocrine cell differentiation [H1 RNA-seq] 0.14
Aberrant expression profile of lncRNA and mRNA in dilated cardiomyopathy by RNA-sequence 0.14
RNA-Seq with and without RNase treatment in PCa cell lines 0.13
Identification of long noncoding RNAs in T-ALL cell lines 0.13
An Open-Label Pilot Study to Evaluate the Efficacy of Tofacitinib in Moderate to Severe Patch Type Alopecia Areata, Totalis and Universalis 0.13
Mutant p63 disrupts the key specification switch from the multipotent cell state to stratified epithelia during epithelial differentiation/in ectodermal dysplasia disorders 0.13
Transcriptome analysis of fetal Klinefelter testis tissue samples compared to controls 0.13
RNA:DNA hybrids in the human genome have distinctive nucleotide characteristics, chromatin composition, and transcriptional relationships 0.12
RNA:DNA hybrids in the human genome have distinctive nucleotide characteristics, chromatin composition, and transcriptional relationships (RNA-seq) 0.12
The Developmental Heterogeneity of Human Natural Killer Cells Defined by Single-cell Transcriptome 0.12
In situ CAPTURE of chromatin interactions by biotinylated dCas9 0.12
RNA-seq transcriptonal profiling in human K562 cells with or without dCas9 and sgRNAs 0.12
Profiling gene expression changes in primary ovarian tumors compared to matched normal fallopian tubes 0.12
Integration of ATAC-seq and RNA-seq Identifies Human Alpha Cell and Beta Cell Signature Genes 0.11
LncRNA DEANR1 facilitates human endoderm differentiation by activating FOXA2 expression 0.11
Glioma-derived miRNA-containing extracellular vesicles induce angiogenesis by reprogramming brain endothelial cells 0.11
Glioma-derived miRNA-containing extracellular vesicles induce angiogenesis by reprogramming brain endothelial cells (longRNA-seq) 0.11
Landscapes of gene translation in hepatocellular carcinoma tumors revealed by ribosome profiling 0.11
High-throughput RNA sequencing on circular RNA profiles of human triple-negative breast cancer and adjacent normal tissues 0.11
AML subtype is a major determinant of the association between prognostic gene expression signatures and their clinical significance. 0.1
AQP5-Expressing Cells Serve as Stem Cells and Cancer Origins in the Distal Stomach 0.1
Recurrent alterations of TNFAIP3 (A20) in T-cell large granular lymphocytic leukemia 0.1
Forkhead domain mutations in FOXA1 drive prostate cancer cell progression 0.1
RNA-seq in LNCaP cell line overexpressing WT or mutant FOXA1 0.1
RNA-seq of SCLC PDX models treated with EP 0.1
RNA-sequencing of the GSI treatment of the CUTLL1 cell line 0.1
Expansion of adult human pancreatic tissue yields organoids harbouring progenitor cells with endocrine differentiation potential 0.09
Identification of PAX7-induced transcriptional changes and PAX7 genomic binding during skeletal myogenic differentiation of H9 embryonic stem cells 0.09
Single cell transcriptome of peritoneal cells 0.09
Gene expression profile of human placenta from T. Cruzi infected mothers 0.09
Transcriptomic Analysis of Endothelial Cells from Fibrovascular Membranes in Proliferative Diabetic Retinopathy 0.08
RNA-sequencing of the brain transcriptome implicates dysregulation of neuroplasticity, circadian rhythms, and GTPase binding in bipolar disorder 0.08
Enhancer Activation Requires Trans-Recruitment of a Mega Transcription Factor Complex (Gro-seq) 0.07
Enhancer Activation Requires Trans-Recruitment of a Mega Transcription Factor Complex 0.07
Increased Neanderthal ancestry in genomic regions associated with lipid catabolism in contemporary Europeans 0.07
Loss of EGFR-DDEF1 signaling in metastatic and unresectable hepatoblastoma 0.07
Transcriptomic profile of intestinal epithelial cells obtained from ileal endoscopic biopsies from newly-diagnosed, pediatric Crohn's disease patients and healthy controls. 0.07
Epigenetic changes induced by Bacteroides fragilis toxin (BFT) [RNA-seq] 0.06
Epigenetic changes induced by Bacteroides fragilis toxin (BFT) 0.06
Biomarkers of Cavernous Angioma with Symptomatic Hemorrhage (CASH) [RNA-seq] 0.06
Biomarkers of Cavernous Angioma with Symptomatic Hemorrhage (CASH) 0.06
Identification of an IL-1-induced gene expression pattern in AR+ PCa cells that mimics the molecular phenotype of AR- PCa cells 0.06
Glucose inhibits cardiac maturation through nucleotide biosynthesis 0.06
The anti-leukemic effect of R-2HG depends on its acting as an m6A mRNA modifier-RNA Seq-Resistant, sensitive and healthy control 0.06
mRNA sequencing of oropharyngeal cancer cell lines 0.06
Gene expression profiling of LNCaP cells following shRNA-mediated knockdown of TMEFF2 and growth in presence and absence of dihydrotestosterone 0.06
Genomic profiling of biliary tract cancer cell lines reveals molecular subtypes and actionable drug targets 0.05
Identification of a LIF-responsive replication-competent human β cell 0.05
Activating Transcription Factor 4 modulated TGFb-induced aggresiveness in triple negative breast cancer vis SMAD2/3/4 and mTORC2 signaling 0.04
Expression profiling by RNA-Seq of breast cancer samples from patients in walnut-consuming and control groups 0.04
The Human Testis Cell Atlas via Single-cell RNA-seq (Healthy men scRNA-seq data set) 0.04
Characterizing the Chemoresistant Ovarian Cancer Population using the Heterogeneous PDX 0.04
siRNA-mediated knockdown 0.04
mRNA-Seq profiling SIX2+ and Foxd1+ cells in mouse embryonic and SIX2+ and SIX2-/MEIS1+ cells human fetal kidney 0.03
Tissue-resident memory T cells mediate immune homeostasis in the human pancreas through the PD-1/PD-L1 pathway 0.03
Leucegene: ALL sequencing 0.02
Altered Hydroxymethylation is seen at regulatory regions in pancreatic cancer and regulates oncogenic pathways [RNA-seq] 0.02
Altered Hydroxymethylation is seen at regulatory regions in pancreatic cancer and regulates oncogenic pathways 0.02
RNA-Seq of the corpus callosum from 12 individuals 0.02
Transcriptome analyses of human pancreatic islets and pseudoislets 0.02
Stapled peptide inhibitors of RAB25 target context-specific phenotypes in cancer 0.01
T47D xenografts treated with various combinations of ER- and PR-targeting therapies 0.01
RNA-seq analysis of PRMT5-regulated genes in irradiated/non-irradiated LNCaP cells 0.01
Genome-wide transcriptome analysis of organotypic rafts derived from human papillomavirus type 16 infected primary keratinocytes [3D raft] 0.01
RelA mutants 'reconstituted' and cell cycle synchronized HCT116 Colorectal Cancer Cells 0.0
The secretome of skin cancer cells activates the mTOR/MYC pathway in healthy keratinocytes and converts them into tumorigenic cells 0.0
Expression profiling of pancreatic adenocarcinoma and ductal adenocarcinoma cell lines. 0.0


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation